| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $140K | -47.7% |
| SG&A Expense | $1.9M | -45.1% |
| Operating Income | -$2.1M | +45.3% |
| Pre-tax Income | -$2.1M | +45.3% |
| Net Income | -$2.1M | +45.3% |
| EPS (Basic) | -$0.18 | +47.1% |
| EPS (Diluted) | -$0.18 | +47.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Current Assets | $130K | -86.1% |
| Total Assets | $134K | -85.8% |
| Current Liabilities | $2.2M | +108.1% |
| Total Liabilities | $2.2M | +108.1% |
| Stockholders' Equity | -$2.1M | -1413.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | +10.5% |
| Capital Expenditures | $11K | +0.0% |
| Investing Cash Flow | -$11K | +0.0% |
| Financing Cash Flow | $903K | -64.6% |
| Free Cash Flow | -$1.6M | +10.5% |